HK Stock Market Move | ZHAOKE OPHTH-B(06622) rose more than 6%, reaching a distribution and supply agreement with AFT for its eye drops.

ZHAOKE OPHTH-B(06622) rose by over 6%, rising by 6.06% to 1.4 Hong Kong dollars as of the time of release, with a trading volume of 2.9909 million Hong Kong dollars. On the news front, Zhaoke Ophthalmology announced yesterday that the company has reached a distribution and supply agreement with AFT Pharmaceuticals Limited, a leading medical health product manufacturer and distributor in New Zealand, for BRIMOCHOLTM PF. BRIMOCHOLTM PF is a preservative-free once-daily pupil-constricting eye drop used as a treatment for loss of near-distance vision due to presbyopia. Under the terms of the agreement, Zhaoke Ophthalmology has the right to grant AFT the exclusive distribution rights for BRIMOCHOLTM PF in Australia and New Zealand, on behalf of the company to obtain drug registration in the local market, as well as exclusive importation, promotion, distribution, marketing, and sale of BRIMOCHOLTM PF. The company will receive a non-refundable and non-deductible upfront payment, as well as additional milestone payments based on regulatory achievements and product sales.